Amid the COVID-19 crisis, the United States market for non invasive prenatal testing (NIPT) estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 – 2030.
Article source: https://dpiresearch.com/us-non-invasive-prenatal-testing-nipt-2022-2030/
